Clinical Trials Logo

HIV Infections clinical trials

View clinical trials related to HIV Infections.

Filter by:

NCT ID: NCT00213005 Completed - HIV Infections Clinical Trials

Safety and Acceptability of Carraguard® in HIV Positive Women and Men

Start date: June 2002
Phase: Phase 1
Study type: Interventional

The study objectives were to assess the mucosal safety of Carraguard® gel when applied vaginally once per day for 14 days by sexually abstinent and sexually active, HIV-positive women; to evaluate the effect of Carraguard® gel on the vaginal flora in these women; to evaluate the effect of Carraguard® gel on shedding of HIV-1 in the genital tract of these women; to evaluate the safety of Carraguard® gel when applied directly to the penis once per day for 7 days by sexually abstinent, HIV-positive men; to assess whether symptoms reported by female and male participants during the study may be related to the use of Carraguard® gel; and to examine dimensions of the acceptability of, and compliance with, the study and placebo products.

NCT ID: NCT00212940 Completed - HIV Infections Clinical Trials

Supportive Therapy for Adherence to ART(STAART)

Start date: October 2000
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a psycho-educational intervention can help people living with HIV handle the changes of treatment adherence.

NCT ID: NCT00212888 Completed - HIV Infections Clinical Trials

Combination Vaccination Before HIV Treatment Interruption

Start date: April 2004
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if vaccination before a structured treatment interruption (STI) is associated with an improvement in immune function, resulting in a delayed and reduced rebound in the amount of HIV virus in the blood.

NCT ID: NCT00209313 Completed - HIV Infections Clinical Trials

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

Start date: March 2005
Phase: Phase 2/Phase 3
Study type: Interventional

The study proposed that both clinical and subclinical HSV reactivation is associated with increased HIV shedding from mucosal surfaces, which may increase the infectiousness of HIV-1/HSV-2 coinfected persons. To test this hypothesis, we will control HSV reactivation with acyclovir, a safe medication that is proven to reduce HSV shedding, and measure HIV levels in blood, genital, and pharyngeal secretions. The study hypothesizes that acyclovir will reduce HIV shedding from mucosal surfaces of HIV-1/HSV-2 coinfected individuals.

NCT ID: NCT00207506 Completed - HIV Infections Clinical Trials

Lay Health Advisors for Sexually Transmitted Disease Prevention

Start date: October 2004
Phase: Phase 1/Phase 2
Study type: Interventional

Non-professional community leaders may be at a great advantage in reaching otherwise hard to reach populations for the purpose of advising on sexually transmitted disease (STD) prevention (lay health advisors), health care access, and model health behavior. Latino migrant farm workers are at increased risk for STD and might benefit from such lay health advisors. The study will examine whether this strategy is a useful one for STD prevention in Latino migrant farm workers in rural and small town areas of North Carolina.

NCT ID: NCT00207142 Completed - HIV Infections Clinical Trials

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

INDUMA
Start date: November 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the proportion of subjects with HIV-1 RNA viral load < 50 c/mL through Week 48 of the Maintenance Phase among HIV-infected subjects with an initial undetectable viral load following an Induction Phase with an ATV/RTV containing HAART regimen, when switched to ATV versus remaining on ATV/RTV, whilst continuing their previous NRTI backbone.

NCT ID: NCT00205283 Completed - HIV Infections Clinical Trials

Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection

Start date: August 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the impact of prospective drug level monitoring and dose-adjustment of nelfinavir (NFV) on the clinical and virologic outcomes in a group of HIV-infected patients who have achieved virologic success while receiving a nelfinavir containing highly active antiretroviral therapy (HAART) regimen.

NCT ID: NCT00205231 Completed - HIV Infections Clinical Trials

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

Start date: May 2002
Phase: N/A
Study type: Interventional

This pilot study will investigate the safety and effect of etanercept in HIV infection by studying HIV replication and immune function (as measured by CD4 counts) in individuals with HIV infection.

NCT ID: NCT00203749 Completed - HIV Infections Clinical Trials

Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand

Start date: December 2004
Phase: Phase 3
Study type: Interventional

This study will evaluate the effectiveness of a combination of clinic- and community-based voluntary counseling and testing programs in preventing HIV in African and Thai communities.

NCT ID: NCT00202228 Completed - HIV Infections Clinical Trials

Lactate Metabolism Study in HIV Infected Persons

Start date: July 2002
Phase: Phase 4
Study type: Interventional

Lactic acidosis is a potentially life-threatening disease associated with the treatment of chronic HIV infection. Although acidosis is rare, hyperlactatemia is common and may have long term consequences yet to be recognized. Lactic acidosis is a manifestation of mitochondrial toxicity; consequences which have yet to be fully recognized and understood. In this study, we propose to look at lactate clearance and production by two methods, in four treatment groups, including HIV positive subjects on highly active antiretroviral therapy (HAART) treatment regimes and without HAART regimes, with liver steatosis and without, and compared with HIV negative controls. Supplementation with cofactors thiamine, niacin and L-carnitine, which may have a positive effect on lactate metabolism by facilitating mitochondrial function, will be studied as well.